N-butyldeoxynojirimycin (miglustat) ameliorates pulmonary fibrosis through inhibition of nuclear translocation of Smad2/3.
Nakamura H, Zhou Y, Sakamoto Y, Yamazaki A, Kurumiya E, Yamazaki R, Hayashi K, Kasuya Y, Watanabe K, Kasahara J, Takabatake M, Tatsumi K, Yoshino I, Honda T, Murayama T.
Nakamura H, et al. Among authors: yamazaki r, yamazaki a.
Biomed Pharmacother. 2023 Apr;160:114405. doi: 10.1016/j.biopha.2023.114405. Epub 2023 Feb 15.
Biomed Pharmacother. 2023.
PMID: 36804125
Free article.